| III-34 Xavier Nicolas Modelling and simulation of alirocumab - Part 2: Population pharmacokinetic/pharmacodynamic analysis using an indirect response model to link drug concentrations with LDL-C Thursday 10:05-11:30 |
| III-34 Xavier Nicolas Modelling and simulation of alirocumab - Part 2: Population pharmacokinetic/pharmacodynamic analysis using an indirect response model to link drug concentrations with LDL-C Thursday 10:05-11:30 |